Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
LAKE FOREST, Calif., Oct. 17, 2017 -- InMode Ltd. announced today that it has appointed Mr. Yair Malca to the role of CFO.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/31a60eae-1877-42a9-b79c-4056d2c073a0
Moshe Mizrahy, CEO of InMode, comments: “I am excited for the changes and continued growth that InMode is experiencing. Mr. Malca has a solid understanding of the medical device industry, and the professional qualifications needed to bring InMode’s financial reporting, planning and analysis to the next level.”
Mr. Malca will be taking on the new role of CFO for InMode, and will be actively involved in all aspects of the business. Mr. Malca will be responsible for ensuring that the global finance and accounting organization enables the company to meet its future growth goals. As a member of the executive team, he contributes to strategic and financial planning efforts, and provides direction in the areas of financial management and compliance.
Mr. Malca, brings a wealth of leadership experience and an in-depth knowledge of finance and operations to InMode. In his previous role, Mr. Malca was the Director of Finance for Jazz Semiconductor. Before that, he served as the Controller of Syneron Inc., an aesthetic medical device company. Mr. Malca holds an MBA from Tel-Aviv University and a BA in in Accounting and Economics from Haifa university.
About InMode
InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team were critical in developing state-of-the-art light, laser, and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.
Yang Phan
Vice-President of Marketing, InMode
[email protected] | 1.855.411.2639 ext4
